Similar articles

• Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.

  Bakris GL, Toto RD, McCullough PA. Bakris GL, et al. J Hum Hypertens. 2005 Feb;19(2):139-44. doi: 10.1038/sj.jhh.1001789. J Hum Hypertens. 2005. PMID: 15457206 Clinical Trial.
• [Prediction, screening and treatment of renal complications of diabetes].

  Marre M, Larger E. Marre M, et al. Rev Prat. 2001 Oct 15;51(16):1769-75. Rev Prat. 2001. PMID: 11795120 French.
• [Current issues in the diagnosis and therapy of diabetic nephropathy].

  de Châtel R, Mogyorósi A, Ziyadeh FN. de Châtel R, et al. Orv Hetil. 1997 Jan 26;138(4):187-93. Orv Hetil. 1997. PMID: 9072751 Review. Hungarian.
• [Microalbuminuria is an early marker for increased morbidity and mortality].

  Bramlage P, Wittchen HU, Pittrow D, Dikow R, Kirch W, Lehnert H, Ritz E. Bramlage P, et al. Fortschr Med Orig. 2003 Feb 27;121 Suppl 1:28-32. Fortschr Med Orig. 2003. PMID: 14732947 German.
• [Diabetic nephropathy].

  Morcos M, Zeier M, Schwenger V. Morcos M, et al. Dtsch Med Wochenschr. 2007 May 11;132(19):1039-42. doi: 10.1055/s-2007-979378. Dtsch Med Wochenschr. 2007. PMID: 17476634 Review. German. No abstract available.